Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Baricitinib is an effective treatment for severe alopecia areata.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Human skin cells produce proenkephalin, which changes with environmental factors and skin diseases.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

The cerium-polypeptide hydrogel effectively heals drug-resistant bacterial wounds by fighting bacteria, reducing inflammation, and promoting tissue repair.

Nanoemulgel is a better way to deliver drugs through the skin for various conditions.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

The new omeprazole nanoemulgel shows promise as a topical treatment for infections.

Nanoparticle-embedded microneedles improve drug delivery through the skin but face challenges in stability and safety.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.